The Role of Glial Cells in Epilepsy and Possible Anti-Epileptic Drug Designs
DOI:
https://doi.org/10.54097/2rm6xm46Keywords:
Astrocyte, gap junction, cytokine, glutamate, hyper-excitation.Abstract
Epilepsy, affecting about 1% of the population, comprises a group of disorders of brains characterized by periodic and unpredictable occurrence of seizures. Seizures are medically intractable in about 30% of patients suffering from epilepsy, they have no response to anti-epileptic drugs (AED) which are currently being used in clinical field. Decades of efforts of scientists has demonstrated glial cells' very crucial role in neuron network. They not only serve to maintain homeostasis, but also interfere communication and general regulation. As the consequence, glial cells also go through damage and lesion during seizures and epilepsy, which further exacerbate pathological condition. This hypothesis can account for lots of AED refractory cases because most of AEDs target only neurons' lesion. In a number of experiments, scientists have demonstrated this hypothesis by finding various striking lesion in glial cells before; during; after epilepsy. Blocking water channels and potassium channels over-expressed by astrocytes; blocking gap junction to decrease diffusion in glial networks; locating these lesion of glial cells and then neutralize the dysfunction are very promising ideas of designing drugs alleviating epilepsy. This paper introduces basic characters of glial cells, putting emphasis on their abnormalities within epileptic brains, corresponding therapy will be discussed.
Downloads
References
Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000; 342: 314 – 9.
Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000; 342: 314 – 9.
Danbolt NC. Glutamate uptake. Prog Neurobiol 2001; 65: 1 – 105.
Charles AC, Merrill JE, Dirksen ER et al. Intercellular signaling in glial cells: calcium waves and oscillations in response to mechanical stimulation and glutamate. Neuron 1991; 6: 983 – 92.
Parpura V, Basarsky TA, Liu F et al. Glutamate-mediated astrocyte-neuron signalling. Nature 1994; 369: 744 – 7.
Vezzani A, French J, Bartfai T et al. The role of inflammation in epilepsy. Nat Rev Neurol 2011; 7: 31 – 40.
van Noort JM, Bsibsi M. Toll-like receptors in the CNS: implications for neurodegeneration and repair. Prog Brain Res 2009; 175: 139 – 48.
Vezzani A, Balosso S, Ravizza T. The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun 2008; 22: 797 – 803.
Dubé C, Vezzani A, Behrens M et al. Interleukin-1beta contributes to the generation of experimental febrile seizures. Ann Neurol 2005; 57: 152 – 5.
Bezzi P, Domercq M, Brambilla L et al. CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat Neurosci 2001; 4: 702 – 10.
Eid T, Thomas MJ, Spencer DD et al. Loss of glutamine synthetase in the human epileptogenic hippocampus: possible mechanism for raised extracellular glutamate in mesial temporal lobe epilepsy. Lancet 2004; 363: 28 – 37.
Aronica E, van Vliet EA, Mayboroda OA et al. Upregulation of metabotropic glutamate receptor subtype mGluR3 and mGluR5 in reactive astrocytes in a rat model of mesial temporal lobe epilepsy. Eur J Neurosci 2000; 12: 2333 – 44.
Theis M, Söhl G, Eiberger J et al. Emerging complexities in identity and function of glial connexins. Trends Neurosci 2005; 28: 188 – 95.
Theis M, Giaume C. Connexin-based intercellular communication and astrocyte heterogeneity. Brain Res 2012; 1487: 88 – 98.
Bedner P, Steinhäuser C. Altered Kir and gap junction channels in temporal lobe epilepsy. Neurochem Int 2013; 63: 682 – 7.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
